Former President and Chief Executive Officer · Traws Pharma, Inc. (TRAW)

Ramesh Kumar

A named executive officer of Traws Pharma in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,207,526

Salary $88,657Stock awards $0Bonus $254,877

FY2018: $1,174,535

1st of 5 named executive officers at Traws Pharma by FY2019 total.

5 named officers on file for Traws Pharma, FY2019

Ramesh Kumar’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Traws Pharma’s whole pay program stands against its peers

  • Traws Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TRAW→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2020 (DEF 14A).

Free

Get Ramesh Kumar’s full pay file as a PDF — free

More than this page: up to 10 years of Ramesh’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Ramesh Kumar compensation by year

Traws Pharma Summary Compensation Table · all 3 fiscal years held
In US dollars, as Traws Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$538,150$569,448$88,657
Bonus$0$135,980$254,877
Stock awards$0$0$0
Option awards$81,890$441,854$0
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$23,581$27,253$863,992
Total$643,621$1,174,535$1,207,526

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. DEF 14A filed April 23, 2020, accession 0001047469-20-002532, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Traws Pharma, Inc. filed document, accession 0001047469-20-002532. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2020.

$644K
$1.2M
$1.2M
FY17
FY18
FY19
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option49—$348.00
Option110—$222.00
Option733—$48.60
Option281—$39.75
Option3,004—$22.50
Option71,040—$6.90
Option1,060—$40.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Traws Pharma, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Traws Pharma’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Ramesh Kumar · this pageFormer President and Chief Executive Officer$1,207,526
Steven FruchtmanPresident and Chief Executive Officer$772,513
Manoj ManiarSenior Vice President, Product Development$576,058
Mark GuerinChief Financial Officer$505,108
Richard WoodmanChief Medical Officer and Senior Vice President, Research and Development$425,312

The full Traws Pharma compensation record

free company brief

This page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ramesh Kumar's compensation dossier · One-time report. No refunds.